MXPA03000905A - Compuestos de poliamina ciclicos como tratamiento contra el cancer. - Google Patents

Compuestos de poliamina ciclicos como tratamiento contra el cancer.

Info

Publication number
MXPA03000905A
MXPA03000905A MXPA03000905A MXPA03000905A MXPA03000905A MX PA03000905 A MXPA03000905 A MX PA03000905A MX PA03000905 A MXPA03000905 A MX PA03000905A MX PA03000905 A MXPA03000905 A MX PA03000905A MX PA03000905 A MXPA03000905 A MX PA03000905A
Authority
MX
Mexico
Prior art keywords
cancer therapy
polyamine compounds
cyclic polyamine
cyclic
compounds
Prior art date
Application number
MXPA03000905A
Other languages
English (en)
Inventor
Benjamin Frydman
Original Assignee
Slil Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Slil Biomedical Corp filed Critical Slil Biomedical Corp
Publication of MXPA03000905A publication Critical patent/MXPA03000905A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA03000905A 2000-08-02 2001-08-02 Compuestos de poliamina ciclicos como tratamiento contra el cancer. MXPA03000905A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22252200P 2000-08-02 2000-08-02
PCT/US2001/024282 WO2002010142A1 (en) 2000-08-02 2001-08-02 Cyclic polyamine compounds for cancer therapy

Publications (1)

Publication Number Publication Date
MXPA03000905A true MXPA03000905A (es) 2003-06-24

Family

ID=22832553

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03000905A MXPA03000905A (es) 2000-08-02 2001-08-02 Compuestos de poliamina ciclicos como tratamiento contra el cancer.

Country Status (7)

Country Link
EP (1) EP1305299A1 (es)
JP (1) JP2004505112A (es)
AU (2) AU2001278143B2 (es)
CA (1) CA2417064A1 (es)
IL (1) IL153864A0 (es)
MX (1) MXPA03000905A (es)
WO (1) WO2002010142A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026347B2 (en) 2002-06-26 2006-04-11 Cellgate, Inc. Porphyrin-polyamine conjugates for cancer therapy
US20070208082A1 (en) 2005-08-10 2007-09-06 John Hopkins University Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
US9822364B2 (en) 2008-03-11 2017-11-21 Yale University Compositions and methods for controlled delivery of inhibitory ribonucleic acids
WO2009114614A2 (en) 2008-03-11 2009-09-17 Yale University Compositions and methods for controlled delivery of inhibitory ribonucleic acids
US10465042B2 (en) 2011-12-02 2019-11-05 Yale University Poly(amine-co-ester) nanoparticles and methods of use thereof
WO2013082529A1 (en) 2011-12-02 2013-06-06 Yale University Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery
US9895451B2 (en) 2011-12-02 2018-02-20 Yale University Formulations for targeted release of agents to low pH tissue environments or cellular compartments and methods of use thereof
IN2012DE00661A (es) 2012-03-07 2015-08-21 Univ Delhi
WO2013173203A1 (en) * 2012-05-15 2013-11-21 Thermo Electron Scientific Instruments Llc Ultra broadband multilayer dielectric beamsplitter coating
US11918695B2 (en) 2014-05-09 2024-03-05 Yale University Topical formulation of hyperbranched polymer-coated particles
US10238581B2 (en) 2014-05-09 2019-03-26 Yale University Hyperbranched polyglycerol-coated particles and methods of making and using thereof
PT3149025T (pt) 2014-05-21 2019-08-01 Entrada Therapeutics Inc Peptídeos penetrantes de células e métodos de fabrico e utilização dos mesmos
US10815276B2 (en) 2014-05-21 2020-10-27 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
EP3185880B1 (en) 2014-08-27 2020-02-12 Ohio State Innovation Foundation Improved peptidyl calcineurin inhibitors
US10682422B2 (en) 2014-11-18 2020-06-16 Yale University Formulations for targeted release of agents under low pH conditions and methods of use thereof
WO2016081621A1 (en) 2014-11-18 2016-05-26 Yale University Formulations for targeted release of agents under low ph conditions and methods of use thereof
CA3014795A1 (en) 2016-02-16 2017-08-24 Yale University Compositions and methods for treatment of cystic fibrosis
US11136597B2 (en) 2016-02-16 2021-10-05 Yale University Compositions for enhancing targeted gene editing and methods of use thereof
WO2017197128A1 (en) 2016-05-11 2017-11-16 Yale University Poly(amine-co-ester) nanoparticles and methods of use thereof
US20200113821A1 (en) 2017-04-04 2020-04-16 Yale University Compositions and methods for in utero delivery
WO2019148194A2 (en) 2018-01-29 2019-08-01 Ohio State Innovation Foundation Peptidyl inhibitors of calcineurin-nfat interaction
WO2019165183A1 (en) 2018-02-22 2019-08-29 Entrada Therapeutics, Inc. Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
EP3790890A4 (en) 2018-05-09 2022-03-02 Ohio State Innovation Foundation CYCLIC PEPTIDES OF CELL PENETRATION WITH ONE OR MORE HYDROPHOBIC RESIDUES
WO2020033951A1 (en) 2018-08-10 2020-02-13 Yale University Compositions and methods for embryonic gene editing in vitro
US11814464B2 (en) 2019-04-29 2023-11-14 Yale University Poly(amine-co-ester) polymers and polyplexes with modified end groups and methods of use thereof
US20220243211A1 (en) 2019-06-21 2022-08-04 Yale University Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
WO2020257779A1 (en) 2019-06-21 2020-12-24 Yale University Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
WO2021022161A1 (en) 2019-07-31 2021-02-04 Yale University Compositions and methods for treating sickle cell disease
US20230233693A1 (en) 2020-06-19 2023-07-27 Yale University Poly(amine-co-ester) polymers with modified end groups and enhanced pulmonary delivery
US20220031633A1 (en) 2020-07-28 2022-02-03 Yale University Poly(amine-co-ester) polymeric particles for selective pulmonary delivery
CA3240179A1 (en) 2021-12-08 2023-06-15 Alexandra Piotrowski-Daspit Surface conjugation to poly(amine-co-ester) nanoparticles for targeting to cells and tissues
WO2023159189A1 (en) 2022-02-18 2023-08-24 Yale University Branched poly(amine-co-ester) polymers for more efficient nucleic expression
CN117088825A (zh) * 2023-10-12 2023-11-21 成都威斯津生物医药科技有限公司 一种可离子化脂质、含该可离子化脂质的药物组合物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4999349A (en) * 1990-03-22 1991-03-12 Bristol-Myers Squibb Co. BU-4164E - A and B, prolyl endopeptidase inhibitors
WO1997031632A1 (en) * 1996-02-27 1997-09-04 Eli Lilly And Company Pharmaceutical compounds

Also Published As

Publication number Publication date
CA2417064A1 (en) 2002-02-07
IL153864A0 (en) 2003-07-31
JP2004505112A (ja) 2004-02-19
AU2001278143B2 (en) 2007-08-09
WO2002010142A1 (en) 2002-02-07
EP1305299A1 (en) 2003-05-02
AU7814301A (en) 2002-02-13

Similar Documents

Publication Publication Date Title
MXPA03000905A (es) Compuestos de poliamina ciclicos como tratamiento contra el cancer.
EP1311262A4 (en) COMBINED TREATMENT AGAINST CANCER
DE60223699D1 (en) Diarylsulfidderivat, dessen additionssalz und immunsuppressivum
MXPA03001419A (es) Combinacion terapeutica de un inhibidor de la proteina de transferencia de esteres de colesterol y atorvastatina.
EP1463438A4 (en) ENDOMURAL THERAPY
ZA200410015B (en) Pharmaceutical salts.
GB0028429D0 (en) Therapy
GB0008710D0 (en) Therapeutic compounds
MXPA03006250A (es) Compuestos heterociclicos terapeuticos.
AU2002226650A8 (en) Redox therapy for tumors
MXPA03006268A (es) Compuestos terapeuticos de cromano.
MXPA03006261A (es) Compuestos terapeuticos de cromano.
MXPA03003632A (es) Metodo para tratamiento de tumores usando terapia de combinacion.
GB2367993B (en) Radiotherapy apparatus
GB0101933D0 (en) Therapy
GB0026015D0 (en) Cancer treatment
EP1463511A4 (en) COMBINATORY ANTICANCER THERAPY
GB0013105D0 (en) Therapeutic compounds
ZA200306403B (en) Cancer treatment.
ZA200304439B (en) Therapeutic treatment.
IT1316431B1 (it) Apparecchio per auricolo terapia.
GB0015215D0 (en) Tumour therapy
GB0029577D0 (en) Therapy
GB0020942D0 (en) Therapy
GB0023422D0 (en) Therapy

Legal Events

Date Code Title Description
FA Abandonment or withdrawal